ArticleFrontiers in oncology2026

A four-miRNA serum panel as a diagnostic biomarker for prostate cancer: an exploratory and validation study.

Zuodong Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.